Ser Educacional (SEER3) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 May, 2026Executive summary
Achieved 112.1% year-over-year growth in adjusted net income, reaching R$76.9 million in 4Q25, and a 29.8% reduction in net debt, with leverage at its lowest since Q1 2021.
Adjusted EBITDA margin expanded by 2.9 percentage points to 26.3%, with adjusted EBITDA up 22.8% to R$150.4 million.
Hybrid education and medical school expansion drove robust cash generation, operational optimization, and consistent profitability.
Six new units became operational, with further expansion planned, focusing on healthcare and law programs in non-capital cities.
Dividend payments of R$61 million were resumed, with a semi-annual policy targeting 30% of net earnings.
Financial highlights
Consolidated net revenue grew 9.4% year-over-year to R$572.9 million in 4Q25, with hybrid learning revenue up 12.3% and digital learning revenue down 7.0%.
Adjusted EBITDA rose 22.8% to R$150.4 million, with margin expanding to 26.3%.
Net income reversed from a loss of R$30 million to a profit of R$74.6 million in 4Q25, with recurring profit nearly doubling.
Net operating cash generation post-CapEx increased 227.9% to R$74.5 million, driven by improved payment punctuality and receivables anticipation.
CapEx decreased to R$23.0 million, representing 4.0% of net revenues.
Outlook and guidance
Strategic focus for 2026 includes organic growth, new unit openings, medical course expansion, and operational efficiency, especially in healthcare and law.
CapEx expected to return to 5%-6% of net revenue, supporting expansion and new unit openings.
Dividend policy reinstated, with semi-annual payments of 30% of net earnings.
Leverage target set between 0.6 and 0.8, balancing growth and shareholder returns.
Latest events from Ser Educacional
- Net income surged 74% with strong on-campus growth, higher margins, and reduced net debt.SEER3
Q1 202619 May 2026 - Revenue and EBITDA surged in 3Q24, driven by health course growth and margin expansion.SEER3
Q3 202419 May 2026 - Adjusted net income rose 8.5% to R$46.2M, with margin and cash flow gains from hybrid and health courses.SEER3
Q2 202419 May 2026 - Record EBITDA and net income driven by hybrid and medical growth, efficiency, and deleveraging.SEER3
Q1 202519 May 2026 - Net income rose 66.4% and adjusted EBITDA increased 25% on strong hybrid and medical growth.SEER3
Q2 202519 May 2026 - Strong 4Q24: EBITDA up 18%, net income up 101%, debt down 9.3%, and dividends resumed.SEER3
Q4 202419 May 2026 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025